We are live on ! Find out more
SILO icon

Silo Pharma
SILO

6 hedge funds and large institutions have $72.3K invested in Silo Pharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

50% more funds holding

Funds holding: 4 → 6 (+2)

0.93% less ownership

Funds ownership: 1.62% → 0.69% (-0.93%)

74% less capital invested

Capital invested by funds: $273K → $72.3K (-$201K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FAIM
Financial Advocates Investment Management
Washington
+$58.5K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.56K
3
FIM
FWL Investment Management
Texas
+$293
4
Wells Fargo
Wells Fargo
California
+$59

Top Sellers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
-$144K
2
SC
Shay Capital
New York
-$92K
3
UBS Group
UBS Group
Switzerland
-$6.2K

SILO Hedge Fund Activity: Q4 2022 in Review

6 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2022, worth a combined $72.3K — down 74% from $273K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SILO positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Financial Advocates Investment Management, opening a new position worth an estimated $58.5K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $144K sold.

  • 6 institutional investors held Silo Pharma (SILO) as of Q4 2022, up from 4 in Q3 2022.
  • Funds reported $72.3K of Silo Pharma stock for Q4 2022, down 74% quarter-over-quarter.
  • 4 funds opened new Silo Pharma positions in Q4 2022 and 2 closed out, a net change of +2 holders.
  • The largest Silo Pharma buyer in Q4 2022 was Financial Advocates Investment Management, an estimated $58.5K added.
  • The largest Silo Pharma seller in Q4 2022 was FNY Investment Advisers, an estimated $144K sold.

Based on aggregated 13F filings for Q4 2022.